The Patent Finder
US

Norepinephrine Compositions and Methods Therefor

US 12,245,996 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Mar 3, 2038 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Jul 11, 2022 as application 17/861,752 · Granted Mar 11, 2025
Base term plus 32 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2018 2038
Clock starts
Jan 30, 2018
Ends no later than
Mar 3, 2038
Granted
Mar 11, 2025
base term patent term adjustment Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
32
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
15
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 32 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 30, 2018, when application 15/883,798, the earliest non-provisional in its chain, was filed (this one was filed Jul 11, 2022)Jan 30, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+32 days, USPTO patent term adjustment recordMar 3, 2038High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Mar 3, 2038Medium confidence

This family

US 10,226,436In force
Jan 2038
Jan 2038
US 10,159,657In force
no later than Jan 2038
no later than Jan 2038
US 10,471,026In force
Jan 2038
Jan 2038
US 10,420,735In force
Jan 2038
Jan 2038
US 10,568,850In force
Jan 2038
Jan 2038
US 10,646,458In force
Jan 2038
Jan 2038
US 11,413,259In force
Jan 2038
Jan 2038
US 12,245,996this patent
no later than Mar 2038
no later than Mar 2038
8 of 15 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 20, 2022
Reel 61482, frame 817
Puri, Navneet; Soppimath, Kumaresh; Akasapu, Prem Sagar; Yadav, Vivek; Ilitchev, Iouri V.; Garapati, Sriramya; Hingorani, TusharNevakar, LLCAssignment of Assignor's Interest
Oct 20, 2022
Reel 61483, frame 255
Nevakar Inc.Nevakar Injectables Inc.Assignment of Assignor's Interest
Oct 20, 2022
Reel 61733, frame 652
Nevakar LLCNevakar Inc.Change of Name
Jan 18, 2023
Reel 62405, frame 329
Nevakar Injectables Inc.Oxford Finance LLCSecurity Interest
May 4, 2023
Reel 63545, frame 646
Nevakar Injectables Inc.H.I.G. Bio - Nevakar, L.P.Patent Security Agreement
May 9, 2023
Reel 63583, frame 948
Nevakar Injectables Inc.Novaquest Co.-Investment Fund IX, L.P.Security Interest
May 9, 2023
Reel 63588, frame 122
Oxford Finance LLCNovaquest Co.-Investment Fund X, L.P.Security Interest
May 15, 2026
Reel 74672, frame 415
Nevakar Injectables Inc.Nevakar Pharmaceuticals, Inc.Assignment of Assignor's Interest
Sep 3, 2026
Reel 75902, frame 289
Novaquest Co.-Investment Fund IX, L.P.Nevakar Injectables Inc.Release of Security Interest
Sep 3, 2026
Reel 75902, frame 359
H.I.G. Bio - Nevakar, L.P.Nevakar Injectables Inc.Release of Security Interest
Sep 3, 2026
Reel 76340, frame 73
Novaquest Co.-Investment Fund X, L.P.Nevakar Inc.; Nevakar Injectables Inc.; Vyluma Inc.Release of Security Interest
Sep 3, 2026
reel/frame not recorded
Novaquest Co.-Investment Fund X, L.P.Nevakar Inc.Release of Security Interest
Sep 3, 2026
reel/frame not recorded
Novaquest Co.-Investment Fund X, L.P.Nevakar Injectables Inc.Release of Security Interest
Sep 3, 2026
reel/frame not recorded
Novaquest Co.-Investment Fund X, L.P.Vyluma Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited